SASB Biotechnology & Pharmaceuticals
SASB
SASB prioritizes sustainability measures for biotech and pharma sectors.
The SASB Biotechnology & Pharmaceuticals costs $0 USD. Renewal costs $0 USD every 12 months.
Key Strengths
- Industry-specific metrics tailored to biotech and pharma materiality
- Widely recognized by institutional investors and ESG rating agencies
- Aligns with IFRS Sustainability Disclosure Standards (ISSB) framework
- Focuses on financially material sustainability topics relevant to capital markets
- Free to access and implement — low barrier to adoption
- Continuously updated through rigorous market feedback and public comment processes
Ideal For
This standard is best suited for publicly traded or investor-facing biotechnology and pharmaceutical companies seeking to align their ESG disclosures with financially material sustainability metrics. It is particularly valuable for sustainability officers, investor relations teams, and CFOs at mid-to-large pharma/biotech firms looking to meet growing investor demand for standardized non-financial reporting.
Target Audiences
Relevant Roles
Industries
Alignment & Recognition
Accrediting Body
Scope
Overview
Requirements & Verification
Renewal & Compliance
Impact & Outcomes
Consider Alternatives If...
Frequently Asked Questions
Quick Facts
Certification
English
2011
Cost Breakdown
Certification Details
Related Certifications
VERIFIED™ Responsible Hospitality
Forbes Travel Guide
Social Accountability International (SA8000)
Social Accountability International
UEBT Certified - Ethical Sourcing system
UEBT
Water Footprint Assessment
Water Footprint Network
WBENC Certification
Women’s Business Enterprise National Council
WELL Equity Rating
International WELL Building Insititute